4-186082920-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003265.3(TLR3):​c.1234C>T​(p.Leu412Phe) variant causes a missense change. The variant allele was found at a frequency of 0.284 in 1,613,766 control chromosomes in the GnomAD database, including 67,672 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L412V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.24 ( 5155 hom., cov: 32)
Exomes 𝑓: 0.29 ( 62517 hom. )

Consequence

TLR3
NM_003265.3 missense

Scores

4
8
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 4.10
Variant links:
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021493137).
BP6
Variant 4-186082920-C-T is Benign according to our data. Variant chr4-186082920-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 41472.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-186082920-C-T is described in Lovd as [Benign]. Variant chr4-186082920-C-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.309 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TLR3NM_003265.3 linkuse as main transcriptc.1234C>T p.Leu412Phe missense_variant 4/5 ENST00000296795.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TLR3ENST00000296795.8 linkuse as main transcriptc.1234C>T p.Leu412Phe missense_variant 4/51 NM_003265.3 P1O15455-1

Frequencies

GnomAD3 genomes
AF:
0.236
AC:
35941
AN:
151972
Hom.:
5148
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0691
Gnomad AMI
AF:
0.268
Gnomad AMR
AF:
0.313
Gnomad ASJ
AF:
0.249
Gnomad EAS
AF:
0.321
Gnomad SAS
AF:
0.246
Gnomad FIN
AF:
0.323
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.298
Gnomad OTH
AF:
0.282
GnomAD3 exomes
AF:
0.279
AC:
70051
AN:
250924
Hom.:
10430
AF XY:
0.280
AC XY:
38032
AN XY:
135724
show subpopulations
Gnomad AFR exome
AF:
0.0647
Gnomad AMR exome
AF:
0.299
Gnomad ASJ exome
AF:
0.256
Gnomad EAS exome
AF:
0.340
Gnomad SAS exome
AF:
0.238
Gnomad FIN exome
AF:
0.325
Gnomad NFE exome
AF:
0.298
Gnomad OTH exome
AF:
0.288
GnomAD4 exome
AF:
0.289
AC:
421977
AN:
1461676
Hom.:
62517
Cov.:
55
AF XY:
0.287
AC XY:
208939
AN XY:
727126
show subpopulations
Gnomad4 AFR exome
AF:
0.0604
Gnomad4 AMR exome
AF:
0.298
Gnomad4 ASJ exome
AF:
0.257
Gnomad4 EAS exome
AF:
0.299
Gnomad4 SAS exome
AF:
0.240
Gnomad4 FIN exome
AF:
0.323
Gnomad4 NFE exome
AF:
0.298
Gnomad4 OTH exome
AF:
0.278
GnomAD4 genome
AF:
0.236
AC:
35960
AN:
152090
Hom.:
5155
Cov.:
32
AF XY:
0.238
AC XY:
17727
AN XY:
74334
show subpopulations
Gnomad4 AFR
AF:
0.0691
Gnomad4 AMR
AF:
0.314
Gnomad4 ASJ
AF:
0.249
Gnomad4 EAS
AF:
0.322
Gnomad4 SAS
AF:
0.246
Gnomad4 FIN
AF:
0.323
Gnomad4 NFE
AF:
0.298
Gnomad4 OTH
AF:
0.283
Alfa
AF:
0.283
Hom.:
14949
Bravo
AF:
0.227
TwinsUK
AF:
0.301
AC:
1117
ALSPAC
AF:
0.287
AC:
1105
ESP6500AA
AF:
0.0710
AC:
313
ESP6500EA
AF:
0.290
AC:
2496
ExAC
AF:
0.271
AC:
32913
Asia WGS
AF:
0.297
AC:
1036
AN:
3478
EpiCase
AF:
0.287
EpiControl
AF:
0.291

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency 83, susceptibility to viral infections Benign:2
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtNov 25, 2016- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF. Associated with susceptibility to infections, rheumatoid arthritis. Some functional evidence to show reduced IFN and TNF secretion in response to stimulation. This may be a risk allele, but unlikely to cause disease on its own -
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
TLR3-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJan 28, 2024This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Susceptibility to HIV infection Benign:1
protective, no assertion criteria providedliterature onlyOMIMAug 08, 2018- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxOct 29, 2019This variant is associated with the following publications: (PMID: 29290528, 24371259, 26298326, 31445170, 28046022, 23240626, 17434873, 18325643, 22549436, 18753640, 20413676, 20472559, 20855885, 21093032, 19016379, 21216866, 22174453, 22537752, 22504413, 21712495, 25304972, 22024499) -
Susceptibility to HIV infection;C2751803:Immunodeficiency 83, susceptibility to viral infections Benign:1
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 13, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T;.;.
Eigen
Pathogenic
0.77
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.85
T;D;D
MetaRNN
Benign
0.0021
T;T;T
MetaSVM
Benign
-1.4
T
MutationAssessor
Pathogenic
4.1
H;.;.
MutationTaster
Benign
2.9e-8
P;P
PrimateAI
Uncertain
0.55
T
PROVEAN
Uncertain
-3.5
D;D;D
REVEL
Uncertain
0.45
Sift
Pathogenic
0.0
D;D;D
Sift4G
Uncertain
0.0070
D;D;D
Polyphen
1.0
D;.;.
Vest4
0.20
MPC
0.34
ClinPred
0.082
T
GERP RS
5.0
Varity_R
0.81
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3775291; hg19: chr4-187004074; COSMIC: COSV57167912; COSMIC: COSV57167912; API